Anteris Technologies Global Corp. Share Price
AVRAnteris Technologies Global Corp. Stock Performance
Open $3.92 | Prev. Close $3.79 | Circuit Range N/A |
Day Range $3.76 - $3.92 | Year Range $2.35 - $8.79 | Volume 5,963 |
Average Traded $3.85 |
Anteris Technologies Global Corp. Share Price Chart
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $3.92 | $3.90 | +0.00% |
12-Nov-25 | $3.92 | $3.90 | +3.72% |
11-Nov-25 | $3.94 | $3.77 | -4.68% |
10-Nov-25 | $4.04 | $3.95 | -0.75% |
07-Nov-25 | $3.88 | $3.98 | -1.73% |
06-Nov-25 | $4.08 | $4.05 | -4.37% |
05-Nov-25 | $4.20 | $4.24 | -1.63% |